Vesugen is a synthetic tripeptide bioregulator (Lys-Glu-Asp) designed to target the cardiovascular system by improving endothelial cell function and blood vessel health. It functions primarily at an epigenetic level to restore youthfulness, flexibility, and performance to damaged or aging vascular tissues.
Enhanced Microcirculation: Stimulates the repair and proliferation of endothelial cells, significantly improving overall blood flow and nutrient delivery to tissues.
Vascular Elasticity: Upregulates endothelial nitric oxide synthase (eNOS) to increase nitric oxide production, which relaxes blood vessels and reduces arterial stiffness.
Atherosclerosis Mitigation: Helps normalize elevated endothelin-1 levels, potentially slowing down vascular tissue degradation and plaque-related pathologies.
Cellular Anti-Aging: Mimics calorie restriction mechanisms by increasing SIRT1 expression, a protein vital for DNA repair and metabolic regulation.
Improved Cell Communication: Boosts connexin protein expression, strengthening the gap junctions that coordinate optimal blood pressure regulation.
Secondary Organ Support: Provides neuroprotective impacts on brain tissue and enhances skin fibroblasts, contributing to broader physical longevity.